ViroChem Pharma, Inc.

275 Armand-Frappier Boulvard,
Laval, Quebec H7V 4A7
Canada,
(450) 978-7700
www.virochempharma.com

ViroChem Pharma, Inc., is a pharmaceutical company focused on hepatitis treatments.

ViroChem Pharma was acquired by Vertex Pharmaceuticals on March 12, 2009.

Join Mergr to view all 111 acquisitions of life science companies in 2009, including 14 acquisitions by private equity firms, and 97 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like ViroChem Pharma.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.